rs67294955
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000531.6(OTC):c.583G>A(p.Gly195Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G195A) has been classified as Pathogenic.
Frequency
Consequence
NM_000531.6 missense
Scores
Clinical Significance
Conservation
Publications
- ornithine carbamoyltransferase deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| OTC | NM_000531.6 | c.583G>A | p.Gly195Arg | missense_variant | Exon 6 of 10 | ENST00000039007.5 | NP_000522.3 | |
| OTC | NM_001407092.1 | c.583G>A | p.Gly195Arg | missense_variant | Exon 8 of 12 | NP_001394021.1 | ||
| OTC | XM_017029556.2 | c.583G>A | p.Gly195Arg | missense_variant | Exon 6 of 9 | XP_016885045.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Pathogenic:3
Experimental studies have shown that this missense change affects OTC function (PMID: 9609999). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt OTC protein function. ClinVar contains an entry for this variant (Variation ID: 97255). This missense change has been observed in individual(s) with OTC deficiency (PMID: 7951259, 9609999, 25433810, 30175132). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 195 of the OTC protein (p.Gly195Arg). -
The p.Gly195Arg variant in the OTC gene has been previously reported in many individuals affected with ornithine transcarbamylase deficiency (Tuchman et al., 1994; Martín-Hernández et al., 2014; Ali et al., 2018; Lu et al., 2020). This variant was absent from large population databases, including the Genome Aggregation Database (http://gnomad.broadinstitute.org/). This variant is present in ClinVar (VCV000097255.13). Functional studies have demonstrated that this variant results in significantly reduced enzyme activity (Kogo et al., 1998). Other disease-associated variants have been described nearby and at this amino acid residue (p.Trp193Gly, p.Trp193Arg, p.Trp193Cys, p.Gly195Ala, p.Asp196Tyr, p.Asp196Asn, p.Asp196Val, p.Asp196Glu). The glycine at position 195 is strongly evolutionarily conserved. Computational tools predict that the p.Gly195Arg variant is deleterious; however, the accuracy of in silico algorithms is limited. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, there is sufficient evidence to classify the p.Gly195Arg variant as pathogenic for X-linked ornithine transcarbamylase deficiency based on the information above. [ACMG evidence codes used: PS4; PM2; PS3_Moderate; PP3; PM1_Supporting] -
- -
not provided Pathogenic:2
- -
Published functional studies found this variant is associated with significantly reduced enzyme activity (PMID: 9609999, 37146589); Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 8786061, 34014557, 9286441, 8112735, 9609999, 32778825, 33272297, 30175132, 7951259, 32934962, 17041896, 37593415, 22728053, 17044854, 29623395, 37146589, 19138872, 32034732, 28324312) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at